Doi Tracey 4

What Happened
Tracey Doi, a director of Quest Diagnostics (DGX), was awarded 1,142 shares via an award/other acquisition reported as 1,142 units at $0.00 on 2026-05-20. The filing identifies these as restricted stock units (RSUs), meaning this was a grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-20; Form 4 filed: 2026-05-21 (timely filing).
• Amount: 1,142 shares reported at $0.00 (award of RSUs).
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: F1 — the award represents restricted stock units; F2 — the reported amount includes shares acquired via dividend reinvestment since the reporting person's last Form 4 under the Amended and Restated Deferred Compensation Plan for Directors.
• Transaction type code: A (award/grant/acquisition).

Context
RSU grants are compensation awards that typically vest over a set schedule and convert to actual shares (and tax liability) only upon vesting; they are not the same as an immediate buy or sale on the open market. Awards and dividend-reinvestment adjustments are common for directors and do not by themselves indicate a buy/sell signal.